Recruiting
Phase 1

Allogeneic CD30.CAR-EBVSTs in Patients with Relapsed or Refractory CD30-Positive Lymphomas

Sponsor:

Baylor College of Medicine

Code:

NCT04288726

Conditions

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Classical Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

CD30.CAR-EBVST cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Baylor College of Medicine on 2025-03-25.